杜兰大学医学中心与哥伦比亚大学的合作关系：病理学面临的机遇与挑战

Krause J R, Salmon B C, Gerber M A

Tulane University Hospital/Clinic, New Orleans, LA, USA.

Clin Lab Manage Rev. 1996 Sep-Oct;10(5):519-20, 522-4.

A joint venture between the largest health-care corporation in the country (Columbia/HCA) and Tulane University Hospital/Clinic was established about 1 year ago. Early indications are that the partnership is successful and mutually beneficial. For Tulane University Medical Center, the joint venture provides financial stability and support for academic centers of excellence. Tulane University Hospital/Clinic will become the referral center for complicated cases from the regional Columbia hospitals. The Tulane University Hospital laboratories are positioned to become the regional referral laboratory for esoteric testing. For the pathologists of the regional Columbia hospitals, the opportunity beckons to form a group of equal partners that will contract with Columbia to provide laboratory services at Columbia hospitals and to consolidate the laboratories in the New Orleans division. Columbia has brought corporate expertise, capital, and opportunities for cost-saving economies of scale to the partnership. Quality and cost-effectiveness of patients care will be emphasized as will research on clinical outcomes. This model of corporate/academic partnership represents a new option for academic medical centers around the country as they respond to the rapid changes in the health-care environment.

该国最大的医疗保健公司（哥伦比亚/HCA）与杜兰大学医院/诊所大约在一年前建立了合资企业。早期迹象表明，这种合作是成功且互利的。对杜兰大学医学中心而言，合资企业为卓越学术中心提供了财务稳定和支持。杜兰大学医院/诊所将成为哥伦比亚地区医院复杂病例的转诊中心。杜兰大学医院实验室有能力成为罕见检测的地区转诊实验室。对于哥伦比亚地区医院的病理学家来说，有机会组建一个平等伙伴团体，与哥伦比亚签订合同，在哥伦比亚医院提供实验室服务，并整合新奥尔良分部的实验室。哥伦比亚为此次合作带来了企业专业知识、资金以及实现成本节约的规模经济机会。将强调患者护理的质量和成本效益，以及临床结果研究。这种企业/学术合作模式为美国各地的学术医疗中心应对快速变化的医疗保健环境提供了一种新选择。